Cargando…

Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles

Alcoholic liver disease (ALD) poses a significant threat to human health, with excessive alcohol intake disrupting the immunotolerant environment of the liver and initiating a cascade of pathological events. This progressive disease unfolds through fat deposition, proinflammatory cytokine upregulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghara, Hiral, Chadha, Prashsti, Zala, Devangi, Mandal, Palash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570533/
https://www.ncbi.nlm.nih.gov/pubmed/37841267
http://dx.doi.org/10.3389/fimmu.2023.1205821
_version_ 1785119789854752768
author Aghara, Hiral
Chadha, Prashsti
Zala, Devangi
Mandal, Palash
author_facet Aghara, Hiral
Chadha, Prashsti
Zala, Devangi
Mandal, Palash
author_sort Aghara, Hiral
collection PubMed
description Alcoholic liver disease (ALD) poses a significant threat to human health, with excessive alcohol intake disrupting the immunotolerant environment of the liver and initiating a cascade of pathological events. This progressive disease unfolds through fat deposition, proinflammatory cytokine upregulation, activation of hepatic stellate cells, and eventual development of end-stage liver disease, known as hepatocellular carcinoma (HCC). ALD is intricately intertwined with stress mechanisms such as oxidative stress mediated by reactive oxygen species, endoplasmic reticulum stress, and alcohol-induced gut dysbiosis, culminating in increased inflammation. While the initial stages of ALD can be reversible with diligent care and abstinence, further progression necessitates alternative treatment approaches. Herbal medicines have shown promise, albeit limited by their poor water solubility and subsequent lack of extensive exploration. Consequently, researchers have embarked on a quest to overcome these challenges by delving into the potential of nanoparticle-mediated therapy. Nanoparticle-based treatments are being explored for liver diseases that share similar mechanisms with alcoholic liver disease. It underscores the potential of these innovative approaches to counteract the complex pathogenesis of ALD, providing new avenues for therapeutic intervention. Nevertheless, further investigations are imperative to fully unravel the therapeutic potential and unlock the promise of nanoparticle-mediated therapy specifically tailored for ALD treatment.
format Online
Article
Text
id pubmed-10570533
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105705332023-10-14 Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles Aghara, Hiral Chadha, Prashsti Zala, Devangi Mandal, Palash Front Immunol Immunology Alcoholic liver disease (ALD) poses a significant threat to human health, with excessive alcohol intake disrupting the immunotolerant environment of the liver and initiating a cascade of pathological events. This progressive disease unfolds through fat deposition, proinflammatory cytokine upregulation, activation of hepatic stellate cells, and eventual development of end-stage liver disease, known as hepatocellular carcinoma (HCC). ALD is intricately intertwined with stress mechanisms such as oxidative stress mediated by reactive oxygen species, endoplasmic reticulum stress, and alcohol-induced gut dysbiosis, culminating in increased inflammation. While the initial stages of ALD can be reversible with diligent care and abstinence, further progression necessitates alternative treatment approaches. Herbal medicines have shown promise, albeit limited by their poor water solubility and subsequent lack of extensive exploration. Consequently, researchers have embarked on a quest to overcome these challenges by delving into the potential of nanoparticle-mediated therapy. Nanoparticle-based treatments are being explored for liver diseases that share similar mechanisms with alcoholic liver disease. It underscores the potential of these innovative approaches to counteract the complex pathogenesis of ALD, providing new avenues for therapeutic intervention. Nevertheless, further investigations are imperative to fully unravel the therapeutic potential and unlock the promise of nanoparticle-mediated therapy specifically tailored for ALD treatment. Frontiers Media S.A. 2023-09-29 /pmc/articles/PMC10570533/ /pubmed/37841267 http://dx.doi.org/10.3389/fimmu.2023.1205821 Text en Copyright © 2023 Aghara, Chadha, Zala and Mandal https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Aghara, Hiral
Chadha, Prashsti
Zala, Devangi
Mandal, Palash
Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title_full Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title_fullStr Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title_full_unstemmed Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title_short Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
title_sort stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570533/
https://www.ncbi.nlm.nih.gov/pubmed/37841267
http://dx.doi.org/10.3389/fimmu.2023.1205821
work_keys_str_mv AT agharahiral stressmechanisminvolvedintheprogressionofalcoholicliverdiseaseandthetherapeuticefficacyofnanoparticles
AT chadhaprashsti stressmechanisminvolvedintheprogressionofalcoholicliverdiseaseandthetherapeuticefficacyofnanoparticles
AT zaladevangi stressmechanisminvolvedintheprogressionofalcoholicliverdiseaseandthetherapeuticefficacyofnanoparticles
AT mandalpalash stressmechanisminvolvedintheprogressionofalcoholicliverdiseaseandthetherapeuticefficacyofnanoparticles